Prospect of Using Cell Product for the Therapy of Skin Defects in Diabetes Mellitus
- Авторы: Lykov A.1,2, Bondarenko N.1,2, Poveshchenko O.1,2, Miller T.1, Poveshchenko A.1,2, Surovtseva M.1,2, Bgatova N.1, Konenkov V.1
-
Учреждения:
- Research Institute of Clinical and Experimental Lymphology
- E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
- Выпуск: Том 164, № 2 (2017)
- Страницы: 266-268
- Раздел: Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)
- URL: https://journals.rcsi.science/0007-4888/article/view/239545
- DOI: https://doi.org/10.1007/s10517-017-3970-0
- ID: 239545
Цитировать
Аннотация
The effectiveness of autologous cell product in the therapy of skin burn wounds was studied in C57B1/6 male mice against the background of streptozotocin-induced diabetes mellitus. In animals with and without modeled diabetes mellitus, significant decrease in skin defect area was observed after single administration of the cell product (bone marrow multipotent mesenchymal stromal cells, fibroblasts or media conditioned by these cells).
Об авторах
A. Lykov
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Автор, ответственный за переписку.
Email: aplykov2@mail.ru
Россия, Novosibirsk; Novosibirsk
N. Bondarenko
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Россия, Novosibirsk; Novosibirsk
O. Poveshchenko
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Россия, Novosibirsk; Novosibirsk
T. Miller
Research Institute of Clinical and Experimental Lymphology
Email: aplykov2@mail.ru
Россия, Novosibirsk
A. Poveshchenko
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Россия, Novosibirsk; Novosibirsk
M. Surovtseva
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Россия, Novosibirsk; Novosibirsk
N. Bgatova
Research Institute of Clinical and Experimental Lymphology
Email: aplykov2@mail.ru
Россия, Novosibirsk
V. Konenkov
Research Institute of Clinical and Experimental Lymphology
Email: aplykov2@mail.ru
Россия, Novosibirsk
![](/img/style/loading.gif)